Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1362893.RABJn1XUyekyXOSIOZe91288Us7FqtLTD6q4WhhPrp3CY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1362893.RABJn1XUyekyXOSIOZe91288Us7FqtLTD6q4WhhPrp3CY130_assertion type Assertion NP1362893.RABJn1XUyekyXOSIOZe91288Us7FqtLTD6q4WhhPrp3CY130_head.
- NP1362893.RABJn1XUyekyXOSIOZe91288Us7FqtLTD6q4WhhPrp3CY130_assertion description "[We have immunized advanced melanoma patients with a HLA-A2-compatible human melanoma line genetically modified to release interleukin-2 (IL-2), to elicit or increase a T cell-mediated anti-melanoma response that may affect distant lesions.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1362893.RABJn1XUyekyXOSIOZe91288Us7FqtLTD6q4WhhPrp3CY130_provenance.
- NP1362893.RABJn1XUyekyXOSIOZe91288Us7FqtLTD6q4WhhPrp3CY130_assertion evidence source_evidence_literature NP1362893.RABJn1XUyekyXOSIOZe91288Us7FqtLTD6q4WhhPrp3CY130_provenance.
- NP1362893.RABJn1XUyekyXOSIOZe91288Us7FqtLTD6q4WhhPrp3CY130_assertion SIO_000772 8930655 NP1362893.RABJn1XUyekyXOSIOZe91288Us7FqtLTD6q4WhhPrp3CY130_provenance.
- NP1362893.RABJn1XUyekyXOSIOZe91288Us7FqtLTD6q4WhhPrp3CY130_assertion wasDerivedFrom befree-2016 NP1362893.RABJn1XUyekyXOSIOZe91288Us7FqtLTD6q4WhhPrp3CY130_provenance.
- NP1362893.RABJn1XUyekyXOSIOZe91288Us7FqtLTD6q4WhhPrp3CY130_assertion wasGeneratedBy ECO_0000203 NP1362893.RABJn1XUyekyXOSIOZe91288Us7FqtLTD6q4WhhPrp3CY130_provenance.